MRM Health raises €55 million in Series B funding led by Biocodex to advance microbiome-based therapeutics for inflammatory diseases.
Amount Raised
€55 Million
Round Type
Series B
Investors
Description
MRM Health NV has successfully closed a €55 million Series B financing round to enhance its microbiome-based therapeutics platform. The funding, led by Biocodex and supported by several investors, will help advance the company's clinical trials. Proceeds will be directed towards completing a Phase 2b trial for its lead product MH002. MRM Health also aims to expand its portfolio through strategic partnerships.
Who else raised in Therapeutics and Biotechnology around the same time
Companies in the same sectors as MRM Health that raised within 45 days of this round, from Fundz verified event records.
- Theriva Biologics raised $13M on October 17, 2025.
- Theriva Biologics raised $4M (Funding Round) on October 16, 2025.
- EVerZom raised $12M (Funding Round) on October 14, 2025.
- Spyre Therapeutics raised $275M (Post-IPO Equity) on October 14, 2025.
- Smartlens raised $5.2M (Funding Round) on October 14, 2025.
- ISOThrive raised $8.1M on October 10, 2025.
Who to call at MRM Health, and when
A new round usually means MRM Health is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day MRM Health raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at MRM Health, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at MRM Health. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment MRM Health raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansMRM Health raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.